Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient
S

Updates in Cellular Therapy for Sickle Cell Disease and Beta-Thalassemia

By Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient FEATURING Scott Peslak
By Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient FEATURING Scott Peslak
56 views
March 4, 2024
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
21:05
Louisville Hematology Highlights

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Feat. R. Gale
28:25
Indy Hematology Review

Managing the Benign Hematology Consult: Treatment Recommendations fo…

Feat. C. Kessler
25:22
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2023

Sickle Cell Disease: 2023 Update

Feat. S. Wilson
42:10
Insights from 2023 ASH Annual Meeting

Highlights in Red Cell and Platelet Disorders From ASH 2023

Feat. M. Blinder
34:26
Michigan Medicine

Hematologic Emergencies

Feat. A. Ahmed
36:54
Cayenne Wellness 15th Annual Hybrid Sickle Cell Disease Educational Summit

Gene Therapy for Sickle Cell Disease: Are We Where They Wanted Us to…

Feat. A. Sharma
09:33
Nirmish Shah

Recent Gene Therapy Approvals in SCD: Clinical and Logistical Consid…

24:48
University of Colorado Division of Hematology

Updates in Therapeutics for Sickle Cell Disease

Feat. G. George
08:11
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "A Novel Beta Globin Frameshift Mutation Cau…

Feat. L. Bilston
12:02
ATS 2023 Insights

ATS 2023 Insights: Airway Function in Sickle Cell Disease: Impact on…

Feat. S. Willen
16:56
ASH 2022 Conference Coverage

ASH 2022: What's Hot in Sickle Cell Disease Research 2022

Feat. E. Klings
32:18
Cayenne Wellness 15th Annual Hybrid Sickle Cell Disease Educational Summit

Sickle Cell Disease 101

Feat. I. Osunkwo
19:02
ATS 2023 Insights

ATS 2023 Insights: Sleep Disordered Breathing in Sickle Cell Disease

Feat. O. Afolabi-Brown
12:31
Martin Steinberg

Current Gene Therapeutic Approach to Sickle Cell Disease

13:57
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Pyruvate Kinase Activators - Targeting Red …

Feat. K. Kuo
14:32
Insights from 2023 EHA® Annual Meeting

EHA® 2023 Insights: "Preliminary Results From the Ph1/2 RUBY Tr…

Feat. R. Hanna
10:22
XIV Eurasian Hematology-Oncology Congress - EHOC 2023

State-of-the-Art in Managing Thalassemias

Feat. M. Cappellini
20:18
BMFcases

ASH 2023 Summary: "Updates in Hereditary TTP and Sickle Cell Di…

Feat. I. Ibrahim, T. Bat, Y. Shen
48:27
Cayenne Wellness 15th Annual Hybrid Sickle Cell Disease Educational Summit

Sickle Cell Disease and Stroke

Feat. C. Fox
24:51
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Therapeutic Induction of Fetal Hemoglobin for Treating Sickle Cell D…

Feat. M. Weiss